Adhesion Barrier Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS25013101 | Research Suite: Report (PDF) & Market Data (Excel)
Adhesion barriers are medical implants that are designed to
prevent the development of adhesions, an abnormal internal scarring that
commonly occurs after surgery. These barriers are essential for keeping tissues
and organs separate while the body heals, reducing the possibility of adhesions
that lead to problems like infertility, chronic discomfort, and intestinal
obstruction.
MARKET
OVERVIEW
The adhesion barrier market is valued at approximately USD 0.7 billion in 2023 and is projected to reach USD 1.54 billion by 2034 exhibiting a compound annual growth rate of 7.4% during the forecast period of 2024-2034. The primary purpose of these barriers is to maintain a physical distance between damaged tissue surfaces during the critical healing period. After this period, the majority of adhesion barriers disintegrate and are absorbed by the body.
GROWTH
DRIVERS
The growing elderly population is one of the primary factors
causing the adhesion barrier market's expansion. As individuals age, they are
more prone to undergoing surgical procedures as a result of various health
issues associated with aging. According to the WHO, the population of people
aged 60 years and older in the world is going to double by 2050, and it is
anticipated that the number of people who are 80 years or older is going to
triple between 2020 and 2050. A higher incidence of surgeries is expected to
result from this demographic shift, which is going to increase the need for
adhesion barriers to stop adhesions and other postoperative problems.
Globally, the number of surgical procedures is increasing
due to improvements in medical technology and greater access to healthcare.
Each year, millions of surgeries are performed across different specialties,
such as cardiovascular, orthopedic, and gynecological fields. For example,
according to data from the British Heart Foundation, more than 32,000 cardiac
procedures were performed in England alone within October 2021. This surge in
surgical interventions necessitates effective solutions such as adhesion
barriers to reduce the risks associated with postoperative adhesions.
MARKET
SEGMENTATION:
By Product
-
·
Synthetic adhesion barriers
o Hyaluronic
Acid
o Regenerated
Cellulose
o Polyethylene
Glycol
o Other
Synthetic adhesion barriers
·
Natural adhesion barrier
o Fibrin-Based
o Collagen
and Proteins
By Formulation
-
·
Film/ Mesh Formulation
·
Gel Formulation
·
Liquid Formulation
·
Other Formulations (Spray)
By Application
-
·
General/Abdominal Surgeries
·
Gynecological Surgeries
o Adhesiolysis
o Ovarian
Surgery
o Myomectomy
o Tubal
Surgery
o Surgical
Treatment of Endometriosis
·
Cardiovascular Surgeries
·
Orthopedic Surgeries
·
Neurological Surgeries
·
Reconstructive Surgeries
·
Urological Surgeries
·
Other Surgeries (Spine Surgeries, etc.)
By End User
-
·
Hospitals
·
Ambulatory Surgical Centers
·
Specialty Clinics
By
Region -
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Adhesion
Barrier Market By Product Segment Review:
Synthetic adhesion barriers are medical devices that are designed to prevent adhesion formation after surgical procedures. These barriers tend to be more cost-effective compared to natural alternatives, which makes them an ideal choice for clinics and hospitals seeking to manage expense without sacrificing patient safety. This economic advantage contributes significantly to their market growth.
Adhesion
Barrier Market By Formulation Segment Review:
The film/ mesh formulation segment is expected to hold the
largest share of this market due to its widespread use in various surgical
procedures. Growing awareness of adhesion-related risks and a
rise in surgical operations globally are driving demand for these products.
Adhesion
Barrier Market By Application Segment Review:
General and abdominal surgeries account for a
significant portion of the adhesive barrier market. The risk of adhesion
formation increases when internal organs are manipulated during these
procedures. Thus, adhesion barriers are used in this segment to create a
physical barrier between tissues during healing.
Adhesion
Barrier Market By End User Segment Review:
On the basis of end-user, hospitals are the
largest segment in the adhesion barrier market. They have state-of-the-art
surgical facilities which allows them to perform a variety of
surgical procedures in various specialties. The demand for adhesion barriers is
driven by the growing number of surgeries carried out in hospitals due to
factors such as an aging population and rising prevalence of chronic diseases.
Adhesion
Barrier Market By Region Segment Review:
The market exhibits significant regional variations, with
North America leading the market in 2024 due to its advanced healthcare
infrastructure, high surgical volumes, and increasing awareness about
postoperative complications.
Adhesion
Barrier Market Regional Synopsis:
The North America is anticipated to dominate the global
market for adhesion barrier due to increasing number of surgical procedures,
technological advancements leading to innovative products, rising healthcare
expenditure facilitating access, and favorable regulatory approvals promoting
market accessibility
The European market is growing because of increasing number
of surgical procedures, growing awareness of post-surgical complications among
healthcare providers and patients, advancements in medical technology leading
to better product offerings.
The Asia Pacific is anticipated to witness the highest CAGR
during the forecast period due to increasing patient population driven by
rising incidences of chronic diseases and injuries that necessitate surgical
procedures.
In Latin America, the market is gradually expanding due to rise
in surgical procedures, and increasing recognition among healthcare providers
and patients about the complications associated with post-surgical adhesions.
The market in Middle East and Africa is witnessing growth potential due to the combination of increasing surgical volumes, advancements in technology, and improvements in healthcare infrastructure across many countries.
Key
Challenges:
The regulatory environment for medical devices, including
adhesion barriers, is rigorous and complex. The process for obtaining marketing
approval is often expensive and time-consuming, often taking multiple years.
This lengthy timeline is likely to discourage companies from investing in
research and development for new adhesion barrier products as there is a high
likelihood of failure in clinical trials.
The development of new adhesion barriers involves a
significant financial investment; however, the success rates for gaining
approval are low. Despite significant expenditures in research and development,
many businesses fail to develop clinically significant data that demonstrates
both efficacy and safety, increasing the likelihood of failure.
The market has witnessed a decrease in technological
innovations due to stringent regulations and high costs associated with product
development. The lack of innovative products is likely to hinder market growth
as healthcare providers are going to be unable to access improved solutions
that are capable of improving patient outcomes.
Adhesion
Barrier Market Competitive Landscape:
The global market for adhesion barrier is characterized by a
diverse range of established companies, each striving to enhance their market
presence through various strategies such as product innovation, strategic
partnerships, geographic expansion, marketing efforts aimed at raising
awareness, competitive pricing strategies, and strict adherence to regulatory
standards.
Companies are investing significantly in research and
development (R&D) to meet the evolving needs of healthcare providers and
patients. This involves developing novel formulations that enhance usability,
safety, and efficacy. For instance, companies are exploring developments in
synthetic adhesion barriers, such as those based on hyaluronic acid or
polyethylene glycol, to improve biocompatibility and bioresorbability of the
product.
Key
Players:
·
Medtronic Plc
·
Johnson & Johnson
·
Integra Lifesciences Corporation
·
FzioMed Inc.
·
Baxter International Inc.
·
Becton, Dickinson and Company
·
Anika Therapeutics
·
MAST Biosurgery
·
Terumo Corporation
·
Betatech Medical
· Other Key & Niche Players